Effects of nattokinase on the patients with eosinophilic chronic rhinosinusitis
Phase 1
- Conditions
- Eosinophilic chronic rhinosinusitis
- Registration Number
- JPRN-UMIN000016980
- Lead Sponsor
- niversity of Fukui
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 320
Inclusion Criteria
Not provided
Exclusion Criteria
1)The patient who is complicated with a nose disease (severe septum deviation, severe allergic rhinitis, nose or paranasal sinus tumor) that make this study difficult. 2)The case that the steroid dosage cannot cancel for the treatment of this disease and other diseases. 3)The case that has allergy for Natto or soybean. 4)Under during the pregnancy or the nursing 5)Patient during medical treatment of immunity 6)The patient who judged that the medical attendant was inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation improvement effect of the nasal polypus 8 weeks after the nattokinase dosage
- Secondary Outcome Measures
Name Time Method Evaluation symptom score, QOL, and CT score 8 weeks after the nattokinase dosage